Ticker
AIMCompany Name
AIM IMMUNOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Current Assets | Current Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 1.02M | 0.1 | $ 10.39M |
3/31/2025 | $ 2.58M | 0.26 | $ 9.77M |
12/31/2024 | $ 4.18M | 0.44 | $ 9.54M |
9/30/2024 | $ 7.57M | 0.75 | $ 10.1M |
6/30/2024 | $ 10.36M | 1.17 | $ 8.84M |
3/31/2024 | $ 11.31M | 1.14 | $ 9.88M |
12/31/2023 | $ 14.56M | 1.68 | $ 8.65M |
9/30/2023 | $ 22.74M | 4.82 | $ 4.72M |
6/30/2023 | $ 28.87M | 10.01 | $ 2.88M |
3/31/2023 | $ 33.16M | 18.05 | $ 1.84M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for AIM IMMUNOTECH INC is calculated as follows: AssetsC [ $ 39.76M ] / LiabilitesC [ $ 795K ]
(=) Current Ratio [ 50.01 ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.2K |
---|---|
min | 0 |
max | 6.79 |
average | 2.02 |
median | 1.62 |
std | 1.44 |